# IPS:

## Patient

|Gender|Age|
|---|---|
|FEMALE|72|

## Allergies and Intolerances

|Allergen|Status|Category|Reaction|Severity|
|---|---|---|---|---|
|No information about allergies|active||||

## Medication List

|Medication|Status|
|---|---|
|Naproxen 500 MG Oral Tablet|ACTIVE|
|Alendronic acid 10 MG Oral Tablet|ACTIVE|
|60 ACTUAT Fluticasone propionate 0.25 MG/ACTUAT / salmeterol 0.05 MG/ACTUAT Dry Powder Inhaler|ACTIVE|
|0.4 ML Enoxaparin sodium 100 MG/ML Prefilled Syringe|ACTIVE|
|NDA020503 200 ACTUAT Albuterol 0.09 MG/ACTUAT Metered Dose Inhaler|ACTIVE|
|Acetaminophen 500 MG Oral Tablet|ACTIVE|
|1 ML Enoxaparin sodium 150 MG/ML Prefilled Syringe|ACTIVE|
|Albuterol 5 MG/ML Inhalation Solution|ACTIVE|
|vancomycin 1000 MG Injection|ACTIVE|
|piperacillin 4000 MG / tazobactam 500 MG Injection|ACTIVE|
|4 ML Norepinephrine 1 MG/ML Injection|ACTIVE|
|1 ML Vasopressin (USP) 20 UNT/ML Injection|ACTIVE|

## Problem List

|Problem|Status|Onset|
|---|---|---|
|Prediabetes|active|1974-07-27|
|Anemia (disorder)|active|1974-07-27|
|Chronic obstructive bronchitis (disorder)|active|1986-08-09|
|Primary fibromyalgia syndrome|active|1988-05-15|
|Osteoporosis (disorder)|active|2012-12-22|
|Cough (finding)|active|2020-02-29|
|Hemoptysis (finding)|active|2020-02-29|
|Chill (finding)|active|2020-02-29|
|Fever (finding)|active|2020-02-29|
|COVID-19|active|2020-02-29|
|Pneumonia (disorder)|active|2020-02-29|
|Hypoxemia (disorder)|active|2020-02-29|
|Respiratory distress (finding)|active|2020-02-29|
|Acute respiratory failure (disorder)|active|2020-02-29|
|Sepsis caused by virus (disorder)|active|2020-02-29|
|Acute pulmonary embolism (disorder)|active|2020-03-02|
|Septic shock (disorder)|active|2020-03-04|
|Acquired coagulation disorder (disorder)|active|2020-03-04|
|Injury of heart (disorder)|active|2020-03-04|
|Heart failure (disorder)|active|2020-03-04|
|Acute respiratory distress syndrome (disorder)|active|2020-03-04|
